US5079353A
(en)
*
|
1987-12-02 |
1992-01-07 |
Chembiomed, Ltd. |
Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
|
EP0588848A1
(de)
*
|
1991-06-10 |
1994-03-30 |
Glycomed Incorporated |
Modifizierte sialyl lewis a verbindungen
|
CA2110797C
(en)
*
|
1991-06-10 |
2001-02-20 |
Andre P. Venot |
Modified sialyl lewis x compounds
|
AU675209B2
(en)
|
1991-10-15 |
1997-01-30 |
Scripps Research Institute, The |
Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
|
WO1994010340A1
(en)
*
|
1992-10-30 |
1994-05-11 |
Mt. Sinai Hospital Corporation |
Method for measuring glycosyltransferase activity
|
US6406894B1
(en)
|
1992-12-11 |
2002-06-18 |
Glycorex Ab |
Process for preparing polyvalent and physiologically degradable carbohydrate-containing polymers by enzymatic glycosylation reactions and the use thereof for preparing carbohydrate building blocks
|
US5811404A
(en)
*
|
1993-05-14 |
1998-09-22 |
Cytel Corporation |
Sialyl Lex analogues as inhibitors of cellular adhesion
|
PL176272B1
(pl)
*
|
1993-05-14 |
1999-05-31 |
Cytel Corp |
Analogi sialilowe Le jako inhibitory adhezji komórkowej
|
US5854218A
(en)
*
|
1993-05-14 |
1998-12-29 |
Cytel Corporation |
Sialyl Lex analogues as inhibitors of cellular adhesion
|
US5559103A
(en)
*
|
1993-07-21 |
1996-09-24 |
Cytel Corporation |
Bivalent sialyl X saccharides
|
DE4431280A1
(de)
|
1994-09-02 |
1996-03-07 |
Hoechst Ag |
Verfahren zur Isolierung und Reinigung von nukleotidaktivierten Zuckern aus biologischen Quellen
|
US5545553A
(en)
*
|
1994-09-26 |
1996-08-13 |
The Rockefeller University |
Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
|
US6030815A
(en)
*
|
1995-04-11 |
2000-02-29 |
Neose Technologies, Inc. |
Enzymatic synthesis of oligosaccharides
|
US5922577A
(en)
*
|
1995-04-11 |
1999-07-13 |
Cytel Corporation |
Enzymatic synthesis of glycosidic linkages
|
US5728554A
(en)
*
|
1995-04-11 |
1998-03-17 |
Cytel Corporation |
Enzymatic synthesis of glycosidic linkages
|
US5876980A
(en)
*
|
1995-04-11 |
1999-03-02 |
Cytel Corporation |
Enzymatic synthesis of oligosaccharides
|
CZ89098A3
(cs)
*
|
1995-09-29 |
1998-09-16 |
Glycim Oy |
Syntetické polylaktosaminy obsahující až multivalentní sLEX a metody pro jejich použití
|
AUPN658795A0
(en)
*
|
1995-11-15 |
1995-12-07 |
Commonwealth Scientific And Industrial Research Organisation |
Method of producing alpha 2, 3 sialyltransferase
|
US6841543B1
(en)
|
1996-01-31 |
2005-01-11 |
President And Fellows Of Harvard College |
Methods of inhibiting production of T helper type 2 cytokines in human immune cells
|
US6033663A
(en)
*
|
1996-04-10 |
2000-03-07 |
Neose Technologies, Inc. |
Nucleic acids encoding GDP-Fucose pyrophosphorylase
|
JP2001502005A
(ja)
|
1996-10-10 |
2001-02-13 |
サイテル コーポレイション |
限外濾過、逆浸透及びナノ濾過を利用する炭水化物の精製
|
DK1015622T3
(da)
*
|
1997-01-16 |
2004-08-02 |
Neose Technologies Inc |
Praktisk sialylering in vitro af rekombinante glycoproteiner
|
WO1999012944A2
(en)
|
1997-09-05 |
1999-03-18 |
Glycim Oy |
SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
|
EP1903114A3
(de)
|
1997-12-01 |
2008-07-23 |
Neose Technologies, Inc. |
Enzymatische Synthese von Gangliosiden
|
US7244601B2
(en)
*
|
1997-12-15 |
2007-07-17 |
National Research Council Of Canada |
Fusion proteins for use in enzymatic synthesis of oligosaccharides
|
US6500661B1
(en)
|
1998-01-15 |
2002-12-31 |
Neose Technologies, Inc. |
Enzymatic conversion of GDP-mannose to GDP-fucose
|
US6689604B1
(en)
|
1998-03-20 |
2004-02-10 |
National Research Council Of Canada |
Lipopolysaccharide α-2,3 sialyltransferase of Campylobacter jejuni and its uses
|
US6194178B1
(en)
|
1998-09-03 |
2001-02-27 |
Synsorb Biotech Inc. |
Method for the production of sialylated oligosaccharides
|
US6503744B1
(en)
|
1999-02-01 |
2003-01-07 |
National Research Council Of Canada |
Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
|
US6699705B2
(en)
*
|
1999-02-01 |
2004-03-02 |
National Research Council Of Canada |
Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
|
US20030170828A1
(en)
*
|
2000-08-22 |
2003-09-11 |
Wei Zou |
Synthesis of complex carbohydrates
|
CA2456725A1
(en)
|
2001-08-17 |
2003-02-27 |
Neose Technologies, Inc. |
Chemo-enzymatic synthesis of sialylated oligosaccharides
|
US7125843B2
(en)
*
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
US7696163B2
(en)
|
2001-10-10 |
2010-04-13 |
Novo Nordisk A/S |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
EP2322229B1
(de)
|
2001-10-10 |
2016-12-21 |
Novo Nordisk A/S |
Neumodulierung und Glykokonjugation von Faktor IX
|
US7157277B2
(en)
*
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
US7265084B2
(en)
*
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
US7265085B2
(en)
*
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycoconjugation methods and proteins/peptides produced by the methods
|
US7179617B2
(en)
|
2001-10-10 |
2007-02-20 |
Neose Technologies, Inc. |
Factor IX: remolding and glycoconjugation of Factor IX
|
US8008252B2
(en)
*
|
2001-10-10 |
2011-08-30 |
Novo Nordisk A/S |
Factor VII: remodeling and glycoconjugation of Factor VII
|
US7399613B2
(en)
*
|
2001-10-10 |
2008-07-15 |
Neose Technologies, Inc. |
Sialic acid nucleotide sugars
|
US7214660B2
(en)
*
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7226903B2
(en)
*
|
2001-10-10 |
2007-06-05 |
Neose Technologies, Inc. |
Interferon beta: remodeling and glycoconjugation of interferon beta
|
US7297511B2
(en)
*
|
2001-10-10 |
2007-11-20 |
Neose Technologies, Inc. |
Interferon alpha: remodeling and glycoconjugation of interferon alpha
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
US7439043B2
(en)
*
|
2001-10-10 |
2008-10-21 |
Neose Technologies, Inc. |
Galactosyl nucleotide sugars
|
DK1578771T3
(da)
*
|
2001-10-10 |
2013-06-10 |
Novo Nordisk As |
Remodellering og glycokonjugering af peptider
|
US7473680B2
(en)
*
|
2001-11-28 |
2009-01-06 |
Neose Technologies, Inc. |
Remodeling and glycoconjugation of peptides
|
WO2003077865A2
(en)
*
|
2002-03-15 |
2003-09-25 |
Baxter International Inc. |
Methods and compositions for directing cells to target organs
|
EP1534725A2
(de)
|
2002-05-16 |
2005-06-01 |
Glycomimetics, Inc. |
Verbindungen und verfahren zur inhibierung von selectinvermittelten funktion
|
MXPA04012496A
(es)
|
2002-06-21 |
2005-09-12 |
Novo Nordisk Healthcare Ag |
Glicoformos del factor vii pegilados.
|
US20040096396A1
(en)
*
|
2002-07-03 |
2004-05-20 |
Glycomimetics, Inc. |
Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
|
MXPA05003843A
(es)
*
|
2002-10-10 |
2006-02-17 |
Us Dept Veterans Affairs |
Deteccion, localizacion y determicnacion de fases de tumores usando linfocitos activados rotulados dirigidos a un epitope especifico.
|
ES2648046T3
(es)
|
2002-11-12 |
2017-12-28 |
The Brigham And Women's Hospital, Inc. |
Vacuna de polisacárido para infecciones estafilocócicas
|
NZ567841A
(en)
|
2003-03-06 |
2010-01-29 |
Seneb Biosciences Inc |
Methods and compositions for the enzymatic synthesis of gangliosides
|
NZ542094A
(en)
|
2003-03-14 |
2008-12-24 |
Neose Technologies Inc |
Branched polymer conjugates comprising a peptide and water-soluble polymer chains
|
WO2007022512A2
(en)
*
|
2005-08-19 |
2007-02-22 |
Neose Technologies, Inc. |
Glycopegylated factor vii and factor viia
|
SG155777A1
(en)
|
2003-04-09 |
2009-10-29 |
Neose Technologies Inc |
Glycopegylation methods and proteins/peptides produced by the methods
|
WO2006127896A2
(en)
*
|
2005-05-25 |
2006-11-30 |
Neose Technologies, Inc. |
Glycopegylated factor ix
|
US7691603B2
(en)
*
|
2003-04-09 |
2010-04-06 |
Novo Nordisk A/S |
Intracellular formation of peptide conjugates
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
US20040219158A1
(en)
*
|
2003-05-02 |
2004-11-04 |
Glycomimetics, Inc. |
Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
|
EP1624847B1
(de)
|
2003-05-09 |
2012-01-04 |
BioGeneriX AG |
Zusammensetzungen und Verfahren zur Herstellung von Glykosylierungsmutanten des menschlichen Wachstumshormons
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
WO2005016949A2
(en)
*
|
2003-08-12 |
2005-02-24 |
Lipoxen Technologies Limited |
Sialic acid derivatives
|
US7361644B2
(en)
*
|
2003-11-19 |
2008-04-22 |
Glycomimetics, Inc. |
Specific antagonist for both E- and P-selectins
|
US20050187171A1
(en)
*
|
2003-11-19 |
2005-08-25 |
Glycomimetics, Inc. |
Glycomimetic antagonists for both E-and P-selectins
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
US7842661B2
(en)
|
2003-11-24 |
2010-11-30 |
Novo Nordisk A/S |
Glycopegylated erythropoietin formulations
|
US7405198B2
(en)
*
|
2003-11-24 |
2008-07-29 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US20080318850A1
(en)
*
|
2003-12-03 |
2008-12-25 |
Neose Technologies, Inc. |
Glycopegylated Factor Ix
|
US7956032B2
(en)
*
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
US20060040856A1
(en)
*
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
EP1765853B1
(de)
|
2004-01-08 |
2015-10-28 |
ratiopharm GmbH |
O-Glykosylierung von G-CSF Peptiden
|
NZ548893A
(en)
|
2004-02-04 |
2009-09-25 |
Biogernerix Ag |
Methods of refolding mammalian glycosyltransferases
|
RU2006138181A
(ru)
*
|
2004-05-04 |
2008-06-10 |
Ново Нордиск Хелс Кеа Аг (Ch) |
О-связанные гликоформы полипептидов и способ их изготовления
|
WO2006010143A2
(en)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
|
WO2006031811A2
(en)
|
2004-09-10 |
2006-03-23 |
Neose Technologies, Inc. |
Glycopegylated interferon alpha
|
US20080108557A1
(en)
*
|
2004-09-29 |
2008-05-08 |
Novo Nordisk Healthcare A/G |
Modified Proteins
|
EP3061461A1
(de)
|
2004-10-29 |
2016-08-31 |
ratiopharm GmbH |
Remodellierung und glykopegylierung von fibroblasten-wachstumsfaktor (fgf)
|
ES2449195T3
(es)
|
2005-01-10 |
2014-03-18 |
Ratiopharm Gmbh |
Factor estimulante de colonias de granulocitos glicopegilado
|
WO2006105426A2
(en)
*
|
2005-03-30 |
2006-10-05 |
Neose Technologies, Inc. |
Manufacturing process for the production of peptides grown in insect cell lines
|
WO2006121569A2
(en)
*
|
2005-04-08 |
2006-11-16 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
US20090036386A1
(en)
*
|
2005-05-25 |
2009-02-05 |
Glycomimetics, Inc |
Heterobifunctional compounds for selectin inhibition
|
ATE528311T1
(de)
*
|
2005-08-09 |
2011-10-15 |
Glycomimetics Inc |
Glycomimetische inhibitoren des pa-il-lectins, pa-iil-lectins oder beider lectine aus pseudomonas
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
DK2264043T3
(da)
*
|
2005-09-02 |
2018-01-29 |
Glycomimetics Inc |
Heterobifunktionelle pan-selektin-inhibitorer
|
WO2007056191A2
(en)
*
|
2005-11-03 |
2007-05-18 |
Neose Technologies, Inc. |
Nucleotide sugar purification using membranes
|
WO2007143052A1
(en)
*
|
2006-06-01 |
2007-12-13 |
Glycomimetics, Inc. |
Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
|
US20080274958A1
(en)
*
|
2006-07-21 |
2008-11-06 |
Neose Technologies, Inc. |
Glycosylation of peptides via o-linked glycosylation sequences
|
US8969532B2
(en)
|
2006-10-03 |
2015-03-03 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
|
MX2009003470A
(es)
|
2006-10-04 |
2009-04-14 |
Novo Nordisk As |
Azucares y glicopeptidos pegilados enlazados a glicerol.
|
WO2008060378A2
(en)
|
2006-10-12 |
2008-05-22 |
Glycomimetics, Inc. |
Glycomimetic replacements for hexoses and n-acetyl hexosamines
|
WO2008073620A2
(en)
*
|
2006-11-02 |
2008-06-19 |
Neose Technologies, Inc. |
Manufacturing process for the production of polypeptides expressed in insect cell-lines
|
JP5511390B2
(ja)
*
|
2007-02-09 |
2014-06-04 |
グリコミメティクス, インコーポレイテッド |
ヘキソースおよびn−アセチルヘキソサミンの置換体を有する糖模倣体の使用方法
|
NZ580030A
(en)
|
2007-04-03 |
2012-06-29 |
Biogenerix Ag |
Methods of treatment using glycopegylated g-csf
|
US20090053167A1
(en)
*
|
2007-05-14 |
2009-02-26 |
Neose Technologies, Inc. |
C-, S- and N-glycosylation of peptides
|
WO2008154639A2
(en)
|
2007-06-12 |
2008-12-18 |
Neose Technologies, Inc. |
Improved process for the production of nucleotide sugars
|
US8039442B2
(en)
|
2007-07-18 |
2011-10-18 |
Glycomimetics, Inc. |
Compounds and methods for treatment of sickle cell disease or complications associated therewith
|
US8207112B2
(en)
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
KR101582841B1
(ko)
|
2008-02-27 |
2016-01-11 |
노보 노르디스크 에이/에스 |
콘쥬게이트된 인자 viii 분자
|
US8895510B2
(en)
|
2008-04-08 |
2014-11-25 |
Glycomimetics, Inc. |
Pan-selectin inhibitor with enhanced pharmacokinetic activity
|
WO2009155108A1
(en)
|
2008-05-30 |
2009-12-23 |
Momenta Pharmaceuticals, Inc. |
Saccharide structures and methods of making and using such structures
|
AU2009257536B2
(en)
*
|
2008-06-13 |
2015-07-02 |
Glycomimetics, Inc. |
Treatment of cancers of the blood using selected glycomimetic compounds
|
BRPI0916365A2
(pt)
|
2008-07-21 |
2018-05-02 |
Brigham & Womens Hospital Inc |
métodos e composições relacionados aos oligossacarídeos de glicosina beta-1,6 sintéticos
|
WO2010126888A1
(en)
*
|
2009-05-01 |
2010-11-04 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
|
US8921328B2
(en)
|
2010-09-14 |
2014-12-30 |
Glycomimetics, Inc. |
E-selectin antagonists
|
SI2794626T1
(en)
|
2011-12-22 |
2018-02-28 |
Glycomimetics, Inc. |
E-SELECTINE ANTAGONIST COMPOUNDS
|
EP2698636A1
(de)
*
|
2012-08-13 |
2014-02-19 |
Fundació Institut d'Investigació Biomèdica de Bellvitge |
Verfahren und Reagenzien zur Vorbeugung und/oder Behandlung von Transplantatabstoßung
|
AU2013355238B2
(en)
|
2012-12-07 |
2017-12-14 |
Glycomimetics, Inc. |
Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells
|
AU2015355136B2
(en)
|
2014-12-03 |
2020-06-25 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
|
US11045485B2
(en)
|
2016-01-22 |
2021-06-29 |
Glycomimetics, Inc. |
Glycomimetic inhibitors of PA-IL and PA-IIL lectins
|
US11291678B2
(en)
|
2016-03-02 |
2022-04-05 |
Glycomimetics, Inc |
Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
|
EP3497131B1
(de)
|
2016-08-08 |
2022-03-09 |
GlycoMimetics, Inc. |
Kombination von t-zell-checkpoint-inhibitoren mit e-selectin- oder cxcr4-inhibitoren oder mit heterobifunktionellen e-selectin- wie auch cxcr4-inhibitoren
|
BR112019006642A2
(pt)
|
2016-10-07 |
2019-07-02 |
Glycomimetics Inc |
antagonistas multiméricos de e-selectina altamente potentes
|
JP7272956B2
(ja)
|
2017-03-15 |
2023-05-12 |
グリコミメティクス, インコーポレイテッド |
E-セレクチンアンタゴニストとしてのガラクトピラノシル-シクロヘキシル誘導体
|
WO2019108750A1
(en)
|
2017-11-30 |
2019-06-06 |
Glycomimetics, Inc. |
Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
|
WO2019133878A1
(en)
|
2017-12-29 |
2019-07-04 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of e-selectin and galectin-3
|
BR112020018184A2
(pt)
|
2018-03-05 |
2021-02-02 |
Glycomimetics, Inc. |
usos de compostos
|
US11845771B2
(en)
|
2018-12-27 |
2023-12-19 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectin and galectin-3
|
CN115343485B
(zh)
*
|
2022-10-18 |
2023-01-06 |
天津德祥生物技术股份有限公司 |
血型抗原三糖偶联物在血型抗体检测中的应用
|